Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Lilly Ventures
MedTech
Virtue Diagnostics nets $100M for affordable in vitro testing
Virtue may be its own reward, but for Virtue Diagnostics, at least, a fresh infusion of venture capital is a close second.
Andrea Park
Jan 6, 2022 10:10am
Lynk inks $50M series B for 3 early-stage trials
Aug 27, 2021 9:55am
After $62M funding round, CRO Fountain Medical nabs new leader
Jan 2, 2020 7:08am
Kymera nets $65M to move lead protein degrader into the clinic
Nov 13, 2018 8:20am
Atlas, Amgen, Lilly back Kymera’s $30M series A
Oct 30, 2017 7:00am
Chutes & Ladders—Novartis lures UCSF cardiovascular scientist
Aug 18, 2017 7:00am
